Post Profile






Mylan Ripped Off the Government, Ironically by Misclassifying EpiPens as a Generic Drug

The US government spent over $1.3 billion on EpiPens from 2011 to 2015. But Mylan, the makers of EpiPen, has been overcharging the government for the life-saving allergy medication by misclassifying it as a generic, rather than a name brand drug. If you don’t know whether to laugh or cry at this point, you’re not alone. Read more...
read more

share

Related Posts


The maker of EpiPen has agreed to pay the government $465 million after allegedly overcharging for the medicine

Business & Finance : Business Insider: Money Game

Mylan, the marker of the EpiPen, has agreed to pay the federal government a $465 million settlement after it allegedly overcharged government healthcare agencies for the medicine, according to a release from the firm. Mylan had unde...

More on Mylan's EpiPen profiteering: It allegedly ripped off Medicaid, too

Business & Finance : Money & Co

Very quietly, on the Friday before a long Federal holiday weekend, Mylan last week paid $465 million to stifle government allegations that it had systematically overcharged Medicaid for its notorious EpiPen medical device. This sum ...

Blink, and you would've missed that another agency is investigating the maker of EpiPen (MYL)

Business & Finance : Business Insider: Money Game

On Friday, Mylan, the maker of EpiPen, announced that it had reached a $465 million settlement with the US Department of Justice for overcharging the government for the life-saving drug. Mylan will not admit to wrongdoing. The settl...

EpiPen Maker Mylan Will Pay $465 Million to Settle Medicaid Overcharging Case

Business & Finance : DealBook

Mylan said the settlement, after the government had said it improperly classified EpiPen as a generic drug, did not imply any admission of wrongdoing.

CONFIRMED: The maker of EpiPen overcharged the government and lawmakers are furious

Business & Finance : Business Insider: Clusterstock

The Centers for Medicare & Medicaid Services (CMS) confirmed to lawmakers that Mylan, the drug company that makes EpiPen, has been overcharging the government for the life-saving allergy medication. And naturally, lawmakers are furi...

Comments


Copyright © 2016 Regator, LLC